Description
Zymovis Forte is an anti-inflammatory enzyme formulation manufactured by ANVIS, containing Trypsin and Chymotrypsin. Each box includes 2 strips of 15 tablets (total 30 tablets). It is indicated for the treatment of inflammatory conditions, especially those related to muscle injury, joint swelling, and post-operative recovery.
Pharmacological class:
- Proteolytic enzymes (systemic enzyme therapy)
Mechanism of action:
Trypsin and Chymotrypsin are proteolytic enzymes that help break down inflammatory proteins and reduce edema. They enhance tissue repair and reduce pain and swelling by modulating the inflammatory cascade.
Indications:
- Musculoskeletal inflammation (sprains, strains, trauma)
- Post-surgical swelling and recovery
- Joint pain and arthritis-related inflammation
- Soft tissue injuries
- Adjunctive therapy in ENT and dental procedures
Benefits:
- Accelerates healing of injured tissues
- Reduces swelling, pain, and redness
- Non-steroidal alternative for inflammation control
- Well-tolerated with minimal gastrointestinal side effects
Packaging:
- Box of 2 x 15 tablets (30 tablets total)
Safety notes:
- Should be taken on an empty stomach for optimal absorption
- Not recommended for patients with bleeding disorders
- Avoid concurrent use with anticoagulants unless supervised
- May cause mild gastrointestinal discomfort in sensitive individuals
Market positioning:
Zymovis Forte offers a non-steroidal enzymatic approach to inflammation management, making it suitable for patients who require anti-inflammatory support without corticosteroids or NSAIDs. Its dual-enzyme formula enhances recovery in orthopedic, surgical, and sports medicine settings.
